Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Enterprise Value (2013 - 2026)

Xencor (XNCR) posted quarterly Enterprise Value of -$384.4 million for Q1 2026, down 334.1% year-over-year from $164.2 million in Q1 2025, and up 11.68% quarter-over-quarter from -$435.2 million in Q4 2025.

Analysis

Xencor (XNCR) Enterprise Value (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Enterprise Value for 14 consecutive years, with -$384.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Enterprise Value fell 334.1% year-over-year to -$384.4 million; the TTM figure through Mar 2026 stood at -$384.4 million (down 334.1% YoY), while the FY2025 annual figure was -$435.2 million, up 4.01% from the prior year.
  • Enterprise Value advanced to -$384.4 million in Q1 2026 per XNCR's latest filing, from -$435.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$60.8 million in Q2 2024 and bottomed at -$551.2 million in Q4 2023.
  • Historically, Enterprise Value has averaged -$238.5 million across 5 years, with a median of -$112.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Enterprise Value soared 79.54% — and 2025, when it slumped 563.28%.
  • Xencor's Enterprise Value stood at -$96.4 million in 2022, then sank by 471.92% to -$551.2 million in 2023, then climbed by 17.73% to -$453.4 million in 2024, then gained by 4.01% to -$435.2 million in 2025, then rose by 11.68% to -$384.4 million in 2026.
  • Business Quant data shows XNCR's Enterprise Value at -$384.4 million in Q1 2026, -$435.2 million in Q4 2025, and -$112.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 818.88 Mn
Mar 31, 2026 508.83 Mn
Dec 31, 2025 665.13 Mn
Sep 30, 2025 450.07 Mn
Jun 30, 2025 156.97 Mn
Mar 31, 2025 336.19 Mn
Dec 31, 2024 1.16 Bn
Sep 30, 2024 939.95 Mn
Jun 30, 2024 687.31 Mn
Mar 31, 2024 872.24 Mn
Dec 31, 2023 743.81 Mn
Sep 30, 2023 756.86 Mn
Jun 30, 2023 1.00 Bn
Mar 31, 2023 1.14 Bn
Dec 31, 2022 981.71 Mn
Sep 30, 2022 984.86 Mn
Jun 30, 2022 1.15 Bn
Mar 31, 2022 1.23 Bn
Dec 31, 2021 2.08 Bn
Sep 30, 2021 1.67 Bn